We are pleased to announce that the upgraded version of the Allplex™2019-nCoV Assay from Seegene is now available.
With the Allplex™SARS-CoV-2 Assay (Cat.# RV10248X) the S gene has been added as another target and now 4 target genes (E gene, S gene / RdRP gene and N gene) can be detected at the same time in a single tube. With this upgrade the Seegene Allplex™SARS-CoV-2 assay, is the only COVID-19 MDx test on the market that can detect 4 target genes, which might be important for a reliable detection of future sequence variations, due to mutations of the Corona virus. It can be applied on Seegene’s automated system that enables high throughput testing and the Real-time PCR test can newly also be run on the Applied Biosystems™ 7500 (SDS software v2.0.5) cycler.
The Allplex™SARS-CoV-2 assay can now also be combined with the Allplex RV™Essential Assay (Cat.# RV9750X) in order to detect the 17 most important respiratory viruses (Flu A and B, RSV A and B, PIV1-4, MPV, adenoviruses, rhinoviruses) simultaneously in the same run.
This complete and economically attractive panel, can be used as primary test for the syndromic testing in the coming flu season, to differentiate between an infection with COVID-19 or other respiratory virus.
Seegene will also launch further smaller panels to identify the SARS-Cov-2 and the major respiratory viruses in a single tube and within 1 hour after extraction. This products are intended for very high throughput syndromic testing in the coming flu season. We will keep you informed about the news and will be happy to provide you with further information.